Adjunctive Psychosocial Interventions and Opioid Abstinence Among Patients Receiving Buprenorphine: A - Takeaways - MDSpire

Adjunctive Psychosocial Interventions and Opioid Abstinence Among Patients Receiving Buprenorphine: A

  • By

  • Michelle R. Lent

  • Emily E. Hurstak

  • Kevin G. Lynch

  • Emily Loscalzo

  • Kimberly Mazur

  • Helen L. Lugo

  • Karen L. Dugosh

  • June 23, 2026

  • 0 min

Share

  • 1

    Opioid use disorder (OUD) is linked to high mortality rates and serious health conditions, complicating recovery efforts.

  • 2

    Medication for opioid use disorder (MOUD) is the first-line treatment, but buprenorphine and naltrexone are underutilized.

  • 3

    This study evaluated the effects of cognitive-behavioral therapy (CBT) and peer recovery support (PRS) on opioid use and treatment retention.

  • 4

    A total of 340 adults with OUD were randomly assigned to four treatment conditions involving MOUD, CBT, PRS, or both.

  • 5

    The study followed CONSORT guidelines and included assessments at multiple time points to evaluate treatment outcomes.

Original Source(s)

Adjunctive Psychosocial Interventions and Opioid Abstinence Among Patients Receiving Buprenorphine: A

  • by Michelle R. Lent, Emily E. Hurstak, Kevin G. Lynch, Emily Loscalzo, Kimberly Mazur, Helen L. Lugo, Karen L. Dugosh

  • June 23, 2026

Related Content

Are Republicans turning against medications for treating opioid addiction?

Nicotine Pods Tied to More Abstinence

A randomized trial compared 5% nicotine and nicotine-free standardized research pod devices in adults who smoked and wanted to switch completely.

Tracking the longitudinal course of physiologic and mental health functioning among individuals in substance use disorder treatment